Manufacture of 1 KG of cgmp L-ENK
Ended Awarded Last action
- Contract number
- 75N95020F00002
- Awardee
-
Bachem Americas Inc. UEI ULM6JMNK5L83
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $827,788
Award facts
- Opportunity
-
- 75N95020R00047 Solicitation number
- Contract value 100% obligated
- $827,787.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Torrance, CA 90505, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$1 | |
| Supplemental Agreement for work within scope | $16,700 | |
| Supplemental Agreement for work within scope | $18,450 | |
| Supplemental Agreement for work within scope | $8,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $784,639 |
About this award
The National Institute on Drug Abuse awarded a delivery order valued at $827,787.59 to Bachem Americas Inc. for the manufacture of 1 kilogram of current Good Manufacturing Practice (cGMP) L-enkephalin (L-ENK) and related contract research organization (CRO) support services for drug substance development and manufacturing. The award was issued on September 18, 2020, with an ultimate completion date of August 31, 2024. This delivery order falls under Bachem Americas' larger Indefinite Delivery/Indefinite Quantity (IDIQ) master contract titled "CRO Support for NCATS Drug Substance Development and Manufacture," which is valued at approximately $49.7 million and extends through May 2031. No set-aside designation was applied to this contract award.
Bachem Americas Inc., a pharmaceutical manufacturing specialist headquartered in Torrance, California, serves as the prime contractor with no major subcontractors noted. The company specializes in Chemistry, Manufacturing, and Controls services supporting the National Center for Advancing Translational Sciences and National Institute on Drug Abuse research initiatives. This particular delivery order supports the agency's drug development programs by providing specialized cGMP manufacturing services for research compounds. The contract notice also references the administrative de-obligation of unexpended fiscal year 2020 funding in accordance with federal spending authority prior to the September 30, 2025, period closure, demonstrating compliance with federal financial management requirements.
Quick answers
Who was awarded contract 75N95020F00002?
75N95020F00002 was awarded to Bachem Americas Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 18, 2020.
How much is contract 75N95020F00002 worth?
The government has obligated $827,788 on 75N95020F00002.
Is contract 75N95020F00002 an order under another contract?
Yes. 75N95020F00002 is a delivery order under HHSN271201700009I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.
Was contract 75N95020F00002 competed?
The extent of competition for 75N95020F00002 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award